The Department of Health today (August 3) endorsed the recall of three batches of Thymoglobuline for IV Injection 25mg/5ml (Registration number: HK-33039) from the market by a licensed drug wholesaler, Sanofi-Aventis Hong Kong Limited, because of a stability issue. |